Biosintez Overview
- Year Founded
-
1955
- Status
-
Acquired/Merged
- Latest Deal Type
-
2ndary - Private
- Financing Rounds
-
4
Biosintez General Information
Description
Manufacturer of pharmaceutical medicines and products based in Penza, Russia. The company engages in manufacturing a variety of dosage forms, including pharmaceuticals for injections, blood substitutes, blood preservatives, ampoules, tablets, ointment, creams, gels and other medicinal products.
Contact Information
Website
www.biosintez.com(Operating Subsidiary)
Corporate Office
- Street Friendship, 4
- Penza, 440033
- Russia
Corporate Office
- Street Friendship, 4
- Penza, 440033
- Russia
Biosintez Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Biosintez Comparisons
Industry
Financing
Details
Biosintez Competitors (3)
One of Biosintez’s 3 competitors is Akrikhin Pharmaceuticals, a Corporate Backed or Acquired company based in Moscow, Russia.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Akrikhin Pharmaceuticals | Corporate Backed or Acquired | Moscow, Russia | ||||
| Adamed Pharma | Corporation | Pienkow, Poland | ||||
| Polpharma | Formerly PE-Backed | Starogard Gdanski, Poland |
Biosintez Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Biosintez FAQs
-
When was Biosintez founded?
Biosintez was founded in 1955.
-
Where is Biosintez headquartered?
Biosintez is headquartered in Penza, Russia.
-
What industry is Biosintez in?
Biosintez’s primary industry is Pharmaceuticals.
-
Is Biosintez a private or public company?
Biosintez is a Private company.
-
What is the current valuation of Biosintez?
The current valuation of Biosintez is .
-
What is Biosintez’s current revenue?
The current revenue for Biosintez is .
-
Who are Biosintez’s investors?
Government of Russia and Mezhregionalnaya Farmatsevticheskaya Proizvodstvenno-Distribyutorskaya Korporatsiya BIOTEK have invested in Biosintez.
-
Who are Biosintez’s competitors?
Akrikhin Pharmaceuticals, Adamed Pharma, and Polpharma are competitors of Biosintez.
-
When was Biosintez acquired?
Biosintez was acquired on 09-Sep-2019.
-
Who acquired Biosintez?
Biosintez was acquired by Sun Pharmaceutical Industries.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process